Clinical Study | Office of Clinical Research

Nemolizumab In Subjects With Prurigo Nodularis

Posted Date: Jan 3, 2022

This is a continuation of a randomized control trial of nemolizumab, an inti-itch drug

Prior Participation In Clinical Trial

Itch, Open Label Extension

Lyssa Casale
513- 558-5650
casale@ucmail.uc.edu

Name*
First Last
Gender*
- Male
- Female
Age*
Phone*
Email*
How did you hear about us?*
Future Communication*
- By submitting this form, I am agreeing to receive future communication about participating in an upcoming research study.
CAPTCHA
This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.
List